Viewing Study NCT02657161


Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2026-01-09 @ 11:32 AM
Study NCT ID: NCT02657161
Status: COMPLETED
Last Update Posted: 2016-01-15
First Post: 2016-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant
Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module